Artiva Biotherapeutics Ratios (2023-2025) | ARTV

Ratios Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
EBT Margin (Quarter) -323.56%42.13%563.87%-5,514.74%
EBIT Margin (Quarter) -338.12%40.56%539.06%-5,773.71%
EBITDA Margin (Quarter) -319.04%42.85%-508.98%-5,603.19%
Operating Margin (Quarter) -338.12%40.56%539.06%-5,773.71%
Net Margin (Quarter) -323.56%42.13%563.87%-5,514.74%
FCF Margin (Quarter) -40.99%-481.32%-6,015.54%
Efficiency
Assets Average (Quarter) 150.75M217.59M200.42M180.33M159.13M139.90M
Equity Average (Quarter) -157.85M-156.73M-168.34M-182.88M4.95M193.82M177.71M158.91M139.13M119.60M
Invested Capital (Quarter) -164.25M-151.45M-162.01M-174.67M-191.10M201.00M186.64M168.78M149.04M129.22M109.97M
Asset Utilization Ratio (Quarter) 0.020.00
Leverage & Solvency
Equity Ratio (Quarter) -1.54-2.520.890.890.880.880.870.84
Valuation
Enterprise Value (Quarter) -53.70M-65.89M19.80M-48.20M50.22M-146.63M-185.43M-165.96M-142.37M-122.97M-189.31M
Return Ratios
Return on Sales (Quarter) -0.03%0.00%0.06%-0.55%0.00%-0.13%-2.47%
Return on Capital Employed (Quarter) -26.44%-32.77%-39.83%-48.11%-58.20%-70.82%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%-0.01%
Return on Equity (Quarter) 0.00%0.00%-0.07%0.00%0.00%0.00%-0.01%-0.01%